Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000389

Drug Information
Trade NameZenapax    
CompanyRoche Laboratories Inc    
IndicationOrgan Transplant Approved    [1]
Therapeutic ClassImmunomodulatory Agents    
CAS NumberCAS 152923-56-3
TargetInterleukin-2 receptorAntibody[2]
Ref 1Disease-modifying agents for multiple sclerosis: recent advances and future prospects. Drugs. 2008;68(17):2445-68. doi: 10.2165/0003495-200868170-00004. To Reference
Ref 2Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. Transplantation. 2009 Apr 15;87(7):1062-8. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543